Delivery Order SPE2DB20D1100-SPE2DB24FD0H6

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $4,730.91 delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a $2,434.19 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $18,665.10 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has a completion date of November 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,026.03 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a period of performance through July 15, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) awarded a $6,914.92 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. This order was placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a $5,523 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565440991 - MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The $1,706.50 contract has an ultimate completion date of March 20, 2025. AmerisourceBergen, a for-profit organization, is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This award is part of AmerisourceBergen's broader...
The U.S. Defense Logistics Agency (DLA) awarded a $1,360.45 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical division, which enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $18,358.36 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the procurement of the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a $999,999,999 contract vehicle that provides a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a $46,796.25 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD0H6
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $4,006.46 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation, and the ultimate completion date is August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by various defense and civilian agencies to supply critical medical supplies and prescription drugs, leveraging its extensive supply chain network to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 10/30/24, 9:36 AM